Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
Daniela K van Santen(Burnet Institute), Laurence Merchadou, Philippe Sogni(Hôpital Saint-Vincent-de-Paul), Margaret Hellard(The Alfred Hospital), Anders Boyd, Marina B. Klein(Royal Victoria Regional Health Centre), Tianhui Ke(University of Melbourne), Rachel Sacks‐Davis(Burnet Institute), Daniela van Santen(Burnet Institute), Jim Young(McGill University), Catrina Mugglin(University of Bern), Juan Berenguer(Instituto de Salud Carlos III), Colette Smit(Stichting HIV Monitoring), Ashleigh C. Stewart(Burnet Institute), Inmaculada Jarrín(Instituto de Salud Carlos III), Laure Esterle, Joseph Doyle(The Alfred Hospital), S. Gillet, Olivier Leleux(Université de Bordeaux), Maria Prins(University of Amsterdam), Camille Gilbert, Dominique Salmon(Assistance Publique – Hôpitaux de Paris), Ashleigh Stewart(Burnet Institute), Gail Matthews(UNSW Sydney), Rebecca Guy(New South Wales Institute of Psychiatry), Janke Schinkel(Amsterdam UMC Location University of Amsterdam), Fabrice Bonnet(Centre Hospitalier Universitaire de Bordeaux), Jason Asselin(Burnet Institute), Karine Lacombe(Inserm), Joshua Dawe, Alisa Pedrana(Burnet Institute), Mark Stoové(Monash University), Anna L. Wilkinson(Burnet Institute), Andri Rauch(University of Bern), Yanqin Zhang, Coralie Khan, Linda Wittkop(Université de Bordeaux), Marc van der Valk(Academic Medical Center)
Cited by 4
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
|Nature Immunology|2022|987
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777